x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAB-0010760
| Product Information | |
|---|---|
| Clonality | Monoclonal |
| Host Species | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Product Description | PI3K/AKT signalling pathway panel contains multiple trial-sized versions of antibody clones against PI 3 Kinase p85 alpha, AKT1, AKT2, AKT3 and mTOR specifically selected for high performance in various applications. They are provided as a sampler panel to allow you to easily evaluate each antibody. |
| Format | Liquid |
| Purity | Affinity purity |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at -20 °C. Please refer to protocols. |
| Storage Buffer | Constituent: 100% PBS |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
